Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Implementation of the Peripherally Inserted Central Venous Catheter for Patients with Hematological Malignancies in a Peruvian Cancer Center

Katia Roque, MD, Daniel J Enriquez, MD, Elera Elizabeth, Emperatriz Ortega, MD, Juan C Haro, MD, Nathaly Poma, MD, Ricardo Ponce, Indira Tirado-Hurtado, Silvia Neciosup, MD, Henry Gomez, PhD

Blood (2019) 134 (Supplement_1): 5845.

https://doi.org/10.1182/blood-2019-126001

Published: 2019

Journal Articles

Bortezomib-Thalidomide-Dexamethasone (VTD) As Salvage Treatment in Patients with Multiple Myeloma Candidates for Transplantation in the Real World

Jule Vasquez, MD, Shirley Quintana, MD, Lourdes Lopez, Cindy Alcarraz, Marco Villena, Silvia Neciosup, MD, Luis Mas, MD, Henry Gomez

Blood (2017) 130 (Supplement 1): 5427.

https://doi.org/10.1182/blood.V130.Suppl_1.5427.5427

Published: 2017

Journal Articles

Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results.

Ruth Pettengell, FRACP, PhD, Pier Luigi Zinzani, MD, PhD, Geetha Narayanan, MD, Fernando Hurtado de Mendoza, MD, Raghunadharao Digumarti, MD, Henry Gomez, MD, Bertrand Coiffier, MD, PhD, Gary Schiller, MD, David A. Rizzieri, MD, Paul Cernohous, MS, Lixia Wang, PhD, Jack Singer, MD

Blood (2010) 116 (21): 2833.

https://doi.org/10.1182/blood.V116.21.2833.2833

Published: 2010

Journal Articles

Phase III Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin's Lymphoma (EXTEND): Results From the Treatment and Follow-up Periods.

Ruth Pettengell, MD, Bertrand Coiffier, MD, Geetha Narayanan, MD, Fernando Hurtado de Mendoza, MD, Raghunadharao Digumarti, MD, Henry Gomez, MD, Pier Luigi Zinzani, MD, Gary J Schiller, MD, David A Rizzieri, MD, Paul Cernohous, Lixia Wang, Jack W. Singer, MD

Blood (2009) 114 (22): 1677.

https://doi.org/10.1182/blood.V114.22.1677.1677

Published: 2009

Journal Articles

Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis

Blood (2008) 112 (11): 580.

https://doi.org/10.1182/blood.V112.11.580.580

Published: 2008

Journal Articles

Alemtuzumab in Patients with Advanced Mycosis Fungoides and Sezary Syndrome.

Brady Beltran-Garate, MD, Henry Gomez, MD, Jose L. Lopez, MD, Mildred Borrego, MD, Mercedes Prieto, MD, Antonio A. Carrasco-Yalan, MD, Julia Huamani, PharmD, Jorge Castillo, MD, Osiris da Costa, MD

Blood (2007) 110 (11): 3425.

https://doi.org/10.1182/blood.V110.11.3425.3425

Published: 2007

Journal Articles

Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).

Blood (2007) 110 (11): 3432.

https://doi.org/10.1182/blood.V110.11.3432.3432

Published: 2007

Journal Articles

Primary Diffuse Large B-Cell Lymphoma of the Testis (PTL): A Prospective Study of Rituximab (R)-CHOP with CNS and Contralateral Testis Prophylaxis. Results of the IELSG 10 Study.

Umberto Vitolo, Emanuele Zucca, Maurizio Martelli, Annalisa Chiappella, Ileana Baldi, Monica Balzarotti, Annarita Conconi, Henry Gomez, Armando Lopez-Guillermo, Giovanni Martinelli, Lorella Orsucci, Vincenzo Pavone, Giuseppe Rossi, Sergio Storti, Mary K. Gospodarowicz, Franco Cavalli, Andreas H. Sarris

Blood (2006) 108 (11): 208.

https://doi.org/10.1182/blood.V108.11.208.208

Published: 2006

Journal Articles

Immunohistochemical Expression Patterns of Germinal Center and Activation B-Cell Markers in Diffuse Large B-Cell Lymphoma. Clinicopathologic Study of 62 Cases from Peru.

Shirley Quintana, MD, Carlos Barrionuevo, MD, Henry Gomez, MD, Silvia Neciosup, MD, Oswaldo Grados, MD, Sandro Casavilca, MD, Claudio Flores, Msc, Luis Casanova, MD

Blood (2006) 108 (11): 4646.

https://doi.org/10.1182/blood.V108.11.4646.4646

Published: 2006

NARROW

Implementation of the Peripherally Inserted Central Venous Catheter for Patients with Hematological Malignancies in a Peruvian Cancer Center

Bortezomib-Thalidomide-Dexamethasone (VTD) As Salvage Treatment in Patients with Multiple Myeloma Candidates for Transplantation in the Real World

Phase 3 Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin Lymphoma (EXTEND): End of Study Results.

Phase III Trial of Pixantrone Dimaleate Compared with Other Agents as Third-Line, Single-Agent Treatment of Relapsed Aggressive Non-Hodgkin's Lymphoma (EXTEND): Results From the Treatment and Follow-up Periods.

Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis

Alemtuzumab in Patients with Advanced Mycosis Fungoides and Sezary Syndrome.

Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).

Primary Diffuse Large B-Cell Lymphoma of the Testis (PTL): A Prospective Study of Rituximab (R)-CHOP with CNS and Contralateral Testis Prophylaxis. Results of the IELSG 10 Study.

Immunohistochemical Expression Patterns of Germinal Center and Activation B-Cell Markers in Diffuse Large B-Cell Lymphoma. Clinicopathologic Study of 62 Cases from Peru.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only